Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT150 in US Veterans With PTSD
NCT07187011Phase 2Not yet recruiting
- Sponsor
- VA San Diego Healthcare System
- Start
- Apr 2026
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Placebo with PT150 (2 arms). Primary endpoint: Clinician Administered PTSD Scale for DSM-5 at 4 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
ORG-34517
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07187011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07187011.